MicroRNA‑181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.30207593
   PubMed Web of Science ®Google Scholar
• Singh S, Singh PP, Roberts LR, Sanchez W. Chemopreventive strategies in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2013;11(1):45–54. doi:10.1038/nrgastro.2013.14323938452
   PubMed Web of Science ®Google Scholar
• Maluccio M, Covey A. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012;62(6):394–399. doi:10.3322/caac.2116123070690
   PubMed Web of Science ®Google Scholar
• Bartel DP. Metazoan MicroRNAs. Cell. 2018;173(1):20–51. doi:10.1016/j.cell.2018.03.00629570994
   PubMed Web of Science ®Google Scholar
• Ambros V. The functions of animal microRNAs. Nature. 2004;431(7006):350–355. doi:10.1038/nature0287115372042
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.14744438
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233. doi:10.1016/j.cell.2009.01.00219167326
   PubMed Web of Science ®Google Scholar
• Liang Y, Li E, Min J, et al. miR-29a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3. Oncol Rep. 2018;40(6):32613272. doi:10.3892/or.2018.6745
   Web of Science ®Google Scholar
• Fang Y, Xue JL, Shen Q, Chen J, Tian L. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma. Hepatology. 2012;55(6):1852–1862. doi:10.1002/hep.2557622234835
   PubMed Web of Science ®Google Scholar
• Wong CC, Wong CM, Tung EK, et al. The microRNA miR-139 suppresses metastasis and progression of hepatocellular carcinoma by down-regulating Rho-kinase 2. Gastroenterology. 2011;140(1):322–331. doi:10.1053/j.gastro.2010.10.00620951699
   PubMed Web of Science ®Google Scholar
• Li N, Fu H, Tie Y, et al. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 2009;275(1):44–53. doi:10.1016/j.canlet.2008.09.03519006648
   PubMed Web of Science ®Google Scholar
• Guichard C, Amaddeo G, Imbeaud S, et al. Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathw ays in hepatocellular carcinoma. Nat Genet. 2012;44(6):694–698. doi:10.1038/ng.225622561517
   PubMed Web of Science ®Google Scholar
• Jung KA, Lee S, Kwak MK. NFE2L2/NRF2 activity is linked to mitochondria and AMP-activated protein kinase signaling in cancers through miR-181c/Mitochondria-encoded cytochrome c oxidase regulation. Antioxid Redox Signal. 2017;27(13):945–961. doi:10.1089/ars.2016.679728383996
   PubMed Web of Science ®Google Scholar
• Su Z, Zhang M, Xu M, et al. MicroRNA181c inhibits prostate cancer cell growth and invasion by targeting multiple ERK signaling pa thway components. Prostate. 2018;78(5):343–352. doi:10.1002/pros.2347829341215
   PubMed Web of Science ®Google Scholar
• Yao L, Wang L, Li F, Gao X, Wei X, Liu Z. MiR181c inhibits ovarian cancer metastasis and progression by targeting PRKCD expression. Int J Clin Exp Med. 2015;8(9):15198–15205.26629004
   PubMed Web of Science ®Google Scholar
• Zhao L, Li Y, Song X, et al. Upregulation of miR-181c inhibits chemoresistance by targeting ST8SIA4 in chronic myelocytic leukemia. Oncotarget. 2016;7(37):60074–60086. doi:10.18632/oncotarget.1105427527856
   PubMedGoogle Scholar
• Devor EJ, Miecznikowski J, Schickling BM, et al. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: an NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017;147(3):648–653. doi:10.1534/genetics.109.10647628969912
   PubMed Web of Science ®Google Scholar
• Eberlein A, Takasuga A, Setoguchi K, et al. Dissection of genetic factors modulating fetal growth in cattle indicates a substantial role of the non-SMC condensin I complex, subunit G (NCAPG) gene. Genetics. 2009;183(3):951–964. doi:10.1534/genetics.109.10647619720859
   PubMed Web of Science ®Google Scholar
• Murphy LA, Sarge KD. Phosphorylation of CAP-G is required for its chromosomal DNA localization during mitosis. Biochem Biophys Res Commun. 2008;377(3):1007–1011. doi:10.1016/j.bbrc.2008.10.11418977199
   PubMed Web of Science ®Google Scholar
• Li S, Xuan Y, Gao B, et al. Identification of an eight-gene prognostic signature for lung adenocarcinoma. Cancer Manag Res. 2018;10:3383–3392. doi:10.2147/CMAR.S17394130237740
   PubMed Web of Science ®Google Scholar
• Arai T, Okato A, Yamada Y, et al. Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC. Cancer Med. 2018;7(5):1988–2002. doi:10.1002/cam4.145529608247
   PubMed Web of Science ®Google Scholar
• Liang ML, Hsieh TH, Ng KH, et al. Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas. Oncotarget. 2016;7(15):19723–19737. doi:10.18632/oncotarget.773626933822
   PubMedGoogle Scholar
• Liu W, Liang B, Liu H, et al. Overexpression of non-SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma. Int J Mol Med. 2017;40(3):731–738. doi:10.3892/ijmm.2017.307928737823
   PubMed Web of Science ®Google Scholar
• Roessler S, Jia HL, Budhu A, et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 2010;70(24):10202–10212. doi:10.1158/0008-5472.CAN-10-260721159642
   PubMed Web of Science ®Google Scholar
• Min J, Feng Q, Liao W, et al. IFITM3 promotes hepatocellular carcinoma invasion and metastasis by regulating MMP9 through p38/MAPK signaling. FEBS Open Bio. 2018;8(8):1299–1311. doi:10.1002/2211-5463.12479
   PubMed Web of Science ®Google Scholar
• Boufraqech M, Zhang L, Jain M, et al. miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3. Endocr Relat Cancer. 2014;21(4):517–531. doi:10.1530/ERC-14-007724781864
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.126211846609
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67(1):7–30. doi:10.3322/caac.2138728055103
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. doi:10.1016/j.jhep.2018.03.01929628281
   PubMed Web of Science ®Google Scholar
• Baer C, Claus R, Plass C. Genome-wide epigenetic regulation of miRNAs in cancer. Cancer Res. 2013;73(2):473–477. doi:10.1158/0008-5472.CAN-12-373123316035
   PubMed Web of Science ®Google Scholar
• Catanzaro G, Sabato C, Russo M, et al. Loss of miR-107, miR-181c and miR-29a-3p promote activation of Notch2 signaling in Pediatric High-Gra de Gliomas (pHGGs). Int J Mol Sci. 2017;18(12):2742. doi:10.3390/ijms18122742
   PubMed Web of Science ®Google Scholar
• Li B, Pu K, Wu X. Identifying novel biomarkers in hepatocellular carcinoma by weighted gene co-expression network analy sis. J Cell Biochem. 2019;1–14.doi: 10.1002/jcb.28420
   Web of Science ®Google Scholar
• Wu M, Liu Z, Zhang A, Li N. Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics an alysis. Medicine (Baltimore). 2019;98(5):e14287. doi:10.1097/MD.000000000001428730702595
   PubMed Web of Science ®Google Scholar
• Liu K, Li Y, Yu B, Wang F, Mi T, Zhao Y. Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells. Can J Physiol Pharmacol. 2018;1–9. doi:10.1139/cjpp-2018-0016
   PubMed Web of Science ®Google Scholar
• Zhang Q, Su R, Shan C, Gao C, Wu P. Non-SMC condensin I complex, subunit G (NCAPG) is a novel mitotic gene required for hepatocellular cancer cell proliferation and migration. Oncol Res. 2018;26(2):269–276. doi:10.3727/096504017X1507596756098029046167
   PubMed Web of Science ®Google Scholar